Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

BVX.L (BVX) Share News

IN BRIEF: Bivictrix selects clinical candidate for leukaemia trial

6th Jun 2023 13:52

Bivictrix Therapeutics PLC - Macclesfield, England-based biotechnology company focusing on cancer therapies - Nominates a clinical candidate for its BVX001 programme after data from a clinical study into the Bi-Cygni antibody drug conjugate showed significant tumour regressions with no observed adverse effects in acute myeloid leukaemia. Read More

UK shareholder meetings calendar - next 7 days

27th Apr 2023 15:49

EARNINGS UPDATES: Ironveld sees interim pretax loss widen on costs

30th Mar 2023 18:39

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

EXECUTIVE CHANGES: Record founder retires; Bivictrix appoints new CFO

1st Mar 2023 16:57

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Wednesday and not separately reported by Alliance News: Read More

TRADING UPDATES: Bivictrix hails cancer therapy candidate

31st Jan 2023 17:35

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

Bivictrix promotes non-executive director to non-executive chair

6th Jan 2023 10:23

(Alliance News) - Bivictrix Therapeutics PLC on Friday said it promoted its non-executive director to non-executive chair. Read More

AIM WINNERS & LOSERS: Bivictrix surges on lead for BVX001 programme

7th Dec 2022 11:12

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday. Read More

Bivictrix identifies lead for antibody drug conjugates programme

7th Dec 2022 10:59

(Alliance News) - Bivictrix Therapeutics PLC on Wednesday said it identified a development lead for its BVX001 programme, which aims to formulate the next-generation of antibody drug conjugates. Read More

BiVictriX Therapeutics reports widening loss following R&D investment

12th Sep 2022 14:19

(Alliance News) - BiVictriX Therapeutics PLC on Monday reported a widening loss in the first half of 2022, as a result of higher research cosrs. Read More

TRADING UPDATES: Byotrol anticipating positive full-year earnings

11th Jul 2022 21:40

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

UK shareholder meetings calendar - next 7 days

24th Mar 2022 15:58

TRADING UPDATES: BiVictriX expands development; Okyo wins US patent

23rd Feb 2022 20:11

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

TRADING UPDATES: Bank of Cyprus swings profit; Sareum loss widens

21st Feb 2022 18:13

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More